Wooton, Richel M.

HRN: 24-01-00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
10/28/2023
IV
1.5 G
Prior To OR
For Repeat Cs G7P6 (6006)
Waiting Final Action 
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
10/29/2023
IVTT
1.5 Grams
Q8 X 3 Doses
SP Repeat CS
Waiting Final Action 
10/28/2023
CEFUROXIME 500MG (TAB)
10/29/2023
11/04/2023
PO
1 Tab
BID X 7 Days
SP Repeat Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: